Montinutra has raised €2M in pre-A funding led by Metsä Spring, a corporate venture unit of Metsä Group, with a syndicate of private investors. 

With the funding, Montinutra will accelerate its internationalization, advance the designing of the industrial demo production plant, and bring new products to market under its Boreal Bioproducts® brand. The company aims to reach 100 million euros in annual revenue by 2035, with the demo plant up and running by 2026.

Read the full article here.